Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
ODM derived from http://clinicaltrials.gov/show/NCT00195507

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
adult
Item
18 Years and older
boolean
C1706450 (UMLS CUI [1])
Psoriasis
Item
Stable, active plaque psoriasis
boolean
C0033860 (UMLS CUI [1])
Failure to other systemic therapies
Item
Failure to respond to the following systemic therapies: Methotrexate, Cyclosporine, PUVA or Fumarate
boolean
C1515119 (UMLS CUI [1,1])
C0162643 (UMLS CUI [1,2])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Interfering skin conditions
Item
Evidence of skin conditions other than psoriasis that would interfere with evaluations of the effect of the study
boolean
C0037274 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
Recent systemic psoriasis therapy
Item
Systemic psoriasis therapy within 28 days prior
boolean
C4316188 (UMLS CUI [1,1])
C3828653 (UMLS CUI [1,2])